Iain Stuart
Fortune : 67 203 $ au 31/07/2026
Fortune : 67 203 $ au 31/07/2026
Dr. Iain A. Stuart is a Chief Scientific Officer at VYNE Therapeutics, Inc. Dr. Stuart was previously employed as a Chief Scientific Officer by Menlo Therapeutics, Inc., a Senior Vice President-Research & Development by VYNE Pharmaceuticals Ltd., a VP-Medical Strategy & Scientific Affairs by Leo Pharma, Inc., a Project Manager-Pharmaceutical Development by Bio Green Med Solution, Inc., and a Senior Director-Study by Inveresk Research Group, Inc. He received his undergraduate degree from Glasgow Caledonian University and a doctorate degree from Glasgow Caledonian University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,07% | 23/07/2026 | 1 919 ( 0,07% ) | 67 203 $ | 31/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Corporate Officer/Principal | 01/01/2016 |
| YARROW BIOSCIENCE, INC. | Directeur Technique/Scientifique/R&D | - |
| YARROW BIOSCIENCE, INC. | Directeur Technique/Scientifique/R&D | - |
| BIO GREEN MED SOLUTION, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Health Technology |
Menlo Therapeutics, Inc.
Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes mechanism-targeted drugs to treat human cancers | Health Technology |
Glasgow Caledonian University
Glasgow Caledonian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Retail Trade |
VYNE Therapeutics, Inc.
VYNE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national